Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$4.97
Market cap
$102.7M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.06
Enterprise value
$51.87M
Founded in 1996, PetMed Express is America's Most Trusted Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct
Highlights
PETS's debt is down by 34% year-on-year and by 8% since the previous quarter
The quick ratio has grown by 33% from the previous quarter and by 21% YoY
The company's net income has surged by 63% QoQ but it fell by 13% YoY
Petmed Express's EPS has surged by 54% QoQ but it has shrunk by 50% YoY
PETS's gross profit is down by 5% year-on-year and by 3.7% since the previous quarter
The revenue has contracted by 4.2% from the previous quarter and by 4.1% YoY
Key stats
What are the main financial stats of PETS
Market
Valuations
Earnings
Shares outstanding
20.66M
Market cap
$102.7M
Enterprise value
$51.87M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.06
Price to sales (P/S)
0.39
EV/EBIT
N/A
EV/EBITDA
8.58
EV/Sales
0.2
Revenue
$259.34M
Gross profit
$71.34M
Net income
-$963,000
EBIT
-$999,000
EBITDA
$6.05M
Free cash flow
-$918,000
Per share
Balance sheet
Liquidity
EPS
-$0.06
EPS diluted
-$0.06
Free cash flow per share
-$0.04
Book value per share
$4.68
Revenue per share
$12.59
TBVPS
$5.04
Total assets
$146.03M
Total liabilities
$49.6M
Debt
$1.21M
Equity
$96.43M
Working capital
$21.95M
Debt to equity
0.01
Current ratio
1.45
Quick ratio
1.1
Net debt/EBITDA
-8.41
Margins
Efficiency
Dividend
EBITDA margin
2.3%
Gross margin
27.5%
Net margin
-0.4%
Operating margin
-0.8%
Return on assets
-0.6%
Return on equity
-1%
Return on invested capital
-18.6%
Return on capital employed
-1%
Return on sales
-0.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PETS stock price
How has the Petmed Express stock price performed over time
Intraday
-2.55%
1 week
-9.8%
1 month
8.52%
1 year
-32.2%
YTD
-34.26%
QTD
35.05%
Financial performance
How have Petmed Express's revenue and profit performed over time
Revenue
$259.34M
Gross profit
$71.34M
Operating income
-$1.97M
Net income
-$963,000
Gross margin
27.5%
Net margin
-0.4%
The company's net income has surged by 63% QoQ but it fell by 13% YoY
PETS's net margin has surged by 60% since the previous quarter but it is down by 33% year-on-year
The company's operating margin fell by 33% QoQ
The operating income is down by 19% from the previous quarter but it is up by 12% YoY
Growth
What is Petmed Express's growth rate over time
Valuation
What is Petmed Express stock price valuation
P/E
N/A
P/B
1.06
P/S
0.39
EV/EBIT
N/A
EV/EBITDA
8.58
EV/Sales
0.2
Petmed Express's EPS has surged by 54% QoQ but it has shrunk by 50% YoY
The price to book (P/B) is 68% lower than the 5-year quarterly average of 3.3 and 3.6% lower than the last 4 quarters average of 1.1
The equity has declined by 3.9% year-on-year but it is up by 3.1% since the previous quarter
The P/S is 74% below the 5-year quarterly average of 1.5 and 2.5% below the last 4 quarters average of 0.4
The revenue has contracted by 4.2% from the previous quarter and by 4.1% YoY
Efficiency
How efficient is Petmed Express business performance
Petmed Express's return on sales has shrunk by 100% QoQ
The ROIC has plunged by 68% from the previous quarter
The company's return on assets has surged by 63% QoQ but it fell by 20% YoY
PETS's ROE has soared by 62% from the previous quarter but it is down by 43% YoY
Dividends
What is PETS's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did Petmed Express financials performed over time
Petmed Express's total assets is 194% more than its total liabilities
The quick ratio has grown by 33% from the previous quarter and by 21% YoY
The company's total liabilities fell by 20% YoY and by 16% QoQ
PETS's debt is 99% smaller than its equity
The company's debt to equity has shrunk by 50% YoY
PETS's debt is down by 34% year-on-year and by 8% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.